Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |